MentionFox
Click Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-01.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Click Therapeutics, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when Click Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Click Therapeutics, Inc. →Get the full cited report on Click Therapeutics, Inc.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Click Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Click Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Click Therapeutics, Inc. See pricing
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 859 filings in Other Health Care, totalled by week. The dot is this raise, $50M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
Checked away from the filing. What is below does not come from the record on sec.gov.
We combine neuroscience with the power of software to create patient-centric digital treatments. Discover our prescription digital therapeutics and software-enhanced drug therapies.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
David Klein is named as Executive Officer and Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
Randall Stanicky is named as Executive Officer on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
Cris De Luca is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
Jeffrey Berkowitz is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
Alex Zisson is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
Maria Forero is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
Muzammil Mansuri is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
On the filing as: Director.
Lezrene Cunningham is named as Ms. Cunningham served as a Director on the date that the board approved the Offering and on the Date of First Sale. She resigned prior to the date hereof. on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
David Friedman is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
Anthony Costello is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
On the filing as: Director.
Bruce Robertson is named as Mr. Robertson was elected a Director after the Date of First Sale and resigned prior to the date hereof. on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
On the filing as: Director.
Douglas Langa is named as Mr. Langa was elected a Director after the Date of First Sale. on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 12 people that filing names.
12 people named on the filing — 2 holding an executive role and 10 as directors only.
Named as of the 2026-10-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Click Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Click Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Click Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Click Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-02 (clicktherapeutics.com).
Each opens in a new tab, filled in for Click Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/click-therapeutics-inc-form-d-000001